Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines. (2023)
Attributed to:
Optimising Innate Host Defence to Combat Antimicrobial Resistance
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.molmed.2023.01.003
PubMed Identifier: 36764906
Publication URI: http://europepmc.org/abstract/MED/36764906
Type: Journal Article/Review
Volume: 29
Parent Publication: Trends in molecular medicine
Issue: 4
ISSN: 1471-4914